/Investor DB

Lightstone Ventures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Carrick Therapeuticscarricktherapeutics.cominDec 2022

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

Timothy Pearson(CEO)Ash Bahl(CSO)inJenny Horsfield(CBO)inStuart McIntosh(CMO)inDavid Sutherland(VP Finance & Controller)

Co-investorsARCH Venture PartnersB Capital GroupB4 CapitalCambridge Innovation CapitalGV (Google Ventures)Revelation Partners+2 more

ProVerumproverummedical.comSeries A · Jan 2022 · $34M

ProVerum is a venture-backed medical device startup developing minimally invasive technologies to treat benign prostatic hyperplasia (BPH).

HardwareHealthtechMedical DevicesDublin, IE

Dr Conor Harkin(Founder)inRíona Ní Ghriallais(Founder)in

Co-investorsAtlantic Bridge VenturesIreland Strategic Investment FundMVM Life Science PartnersOrbiMed

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.